Vaxart

$6.02
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.44 (-6.92%) Today
+$0.10 (+1.69%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Vaxart and other stocks, options, and ETFs commission-free!

About VXRT

Vaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines. Its products include Influenza, Norovirus and Respiratory Syncytial Virus. The company was founded in 2004 and is headquartered in South San Francisco, CA. The listed name for VXRT is Vaxart, Inc Common Stock.

CEO
Andrei Floroiu
Employees
14
Headquarters
South San Francisco, California
Founded
2004
Market Cap
698.16M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
9.41M
High Today
$6.43
Low Today
$5.71
Open Price
$6.15
Volume
10.55M
52 Week High
$24.90
52 Week Low
$1.08

VXRT Earnings

-$0.39
-$0.26
-$0.13
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
-$0.13 per share
Replay Earnings Call

You May Also Like

ACSI
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure